Cleveland Clinic’s new center will make it easier for more patients to access and benefit from the most innovative and effective treatments in endoluminal surgery.
Cleveland Clinic has used endoscopic submucosal dissection since 2013 to treat patients with early-stage gastric and esophageal tumors. Dr. Bhatt, who introduced the technique to the health system, discusses its evolution, clinical application, and the results of new outcomes research.
A new study presented at ACG 2018 helps make the argument for ESD en-bloc resection of high-risk polyps. It shows that with a select patient population, this type of resection may be truly beneficial and worth the extra effort. Dr. Amit Bhatt explains.
Unable to be operated on at her local hospital, a 59-year-old with a 7 cm esophageal squamous cell cancer undergoes ESD and remains cancer-free.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Gallstones are common in the United States, affecting an estimated 1 in 7 adults. Fortunately, they are asymptomatic in up to 80% of cases, and current guidelines do not recommend cholecystectomy unless they cause symptoms.
An in-depth look at the current indications for endoscopic submucosal dissection in the evaluation and treatment of patients with early gastrointestinal neoplasms.
A surprising rise in gastric cancer among FAP patients caused physicians to change their surveillance techniques.
A new study investigates the relationship between bariatric surgery and changes in bile duct diameter. Amit Bhatt, MD, explains the findings.
A look at why hydroxyethyl starch is the best pick of seven common fluids used as injectate during ESD in the U.S. Dr. Amit Bhatt explains the findings.
Endoscopic submucosal dissection, a technique pioneered in Japan, is offering a less invasive alternative to surgery for patients with early gastrointestinal tumors.